Neurocrine Biosciences, Inc.
NBIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $341 | $250 | $155 | $90 |
| Dep. & Amort. | $27 | $21 | $16 | $11 |
| Deferred Tax | -$123 | -$57 | $19 | $4 |
| Stock-Based Comp. | $196 | $194 | $173 | $134 |
| Change in WC | -$19 | $28 | -$67 | $17 |
| Other Non-Cash | $174 | -$47 | $45 | $1 |
| Operating Cash Flow | $595 | $390 | $339 | $257 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$38 | -$28 | -$17 | -$23 |
| Net Acquisitions | $0 | $0 | -$43 | $0 |
| Inv. Purchases | -$1,056 | -$1,411 | -$629 | -$805 |
| Inv. Sales/Matur. | $968 | $972 | $511 | $698 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$127 | -$467 | -$177 | -$130 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$309 | $0 | -$279 | -$0 |
| Stock Issued | $122 | $65 | $45 | $28 |
| Stock Repurch. | -$300 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$487 | $65 | -$234 | $27 |
| Forex Effect | $0 | $0 | -$1 | $0 |
| Net Chg. in Cash | -$18 | -$12 | -$73 | $154 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $259 | $271 | $344 | $190 |
| End Cash | $241 | $259 | $271 | $344 |
| Free Cash Flow | $557 | $362 | $323 | $233 |